DAVID E. MATYAS is a Member of the Firm in the Health Care and Life Sciences practice, in the firm's Washington, DC, office, where he serves as the Managing Shareholder for the office. He practices in the firm's Health Care Fraud Practice Group, which focuses on federal and state fraud issues such as anti-kickback, self-referral, false claims and regulatory compliance. Mr. Matyas also practices in the firm's Government and Commercial Reimbursement Practice Group, which concentrates on legal and regulatory matters arising under Medicare, Medicaid, and other third-party payment programs.
Mr. Matyas represents an array of health care providers including hospitals and health systems, pharmaceutical and medical device manufacturers, academic medical centers, retail and specialty pharmacies, ambulatory surgery centers, home health agencies, and physician organizations. He also advises investors and other financial institutions that invest in or support the health care industry.
- Represents and defends health care entities in connection with government audits and investigations
- Helps clients develop, implement, and evaluate health care corporate compliance programs
- Counsels clients in planning and structuring transactions and business arrangements to minimize fraud and abuse and understand reimbursement implications in matters related to health care transactions
- Advises clients on legal and regulatory matters in connection with investment documents, offering memoranda, filings with the SEC, and other transactional documents
- Participates in administrative rulemaking processes
- Serves as special regulatory/compliance counsel to a number of boards of directors
In 2012, Mr. Matyas joined the Board of Directors for the Community Health Accreditation Program (CHAP), a non-profit accrediting body for more than 5,000 community-based health care organizations worldwide (home health, hospice, home medical equipment). From 2005 to 2008, by appointment of the Secretary of the Department of Health & Human Services, Mr. Matyas served on the Advisory Committee on Blood Safety & Availability, which provides advice on broad public health, ethical and legal issues related to the nation's supply of blood and blood products. From 2002 to 2008, Mr. Matyas served as a member of the Board of Directors for the American Health Lawyers Association (AHLA). In 2015, Mr. Matyas was elected as a Fellow of AHLA, in recognition of his career-long achievements, contributions and tenure with AHLA, and continuing service and leadership in the legal profession.
Mr. Matyas was elected to the BTI Client Service All-Star Team in 2012 and 2013 for his "extraordinary client service" and "willingness to go above and beyond expectations." The BTI survey identifies and ranks an exclusive list of attorneys—identified solely through client feedback from in-house counsel at Fortune 1000 companies. In addition, Mr. Matyas achieved the "Client Service MVP" ranking from BTI in 2013, which honors attorneys for delivering superior client service year after year. Mr. Matyas has also been listed in Chambers USA: America's Leading Lawyers for Business (2007 to 2020) and recommended by The Legal 500 United States (2011 to 2020), which named him to The Legal 500 Hall of Fame (2017, 2020) and cited him as a "Leading Lawyer" in the Healthcare: Advice to Service Providers category (2015 to 2019). He was selected by his peers for inclusion in The Best Lawyers in America© (2011 to 2021) in the field of Health Care Law and named on the Washington DC Super Lawyers list (2007 to 2020) in the area of Health Care. In 2020, Mr. Matyas was among the attorneys recognized by Leaders League in the “Best Law Firms for Healthcare” survey. Mr. Matyas has also been cited in Who's Who Legal: Healthcare (2020). In both 2005 and 2010, Mr. Matyas was selected by the editors of Nightingale's Healthcare News as one of the "Outstanding Fraud & Compliance Lawyers."
Mr. Matyas is a frequent speaker and author on the subjects of health care fraud, corporate compliance programs, the Stark Law, mergers and acquisitions in the health care industry, and other health-related topics. He is a coauthor of Legal Issues in Health Care Fraud and Abuse: Navigating the Uncertainties, 4th ed., published by AHLA in June 2012.
- University of Texas School of Law (J.D., 1992)
- University of Pennsylvania (B.A., 1990)
- District of Columbia
- New Jersey
- New York
- American Bar Association
- American Health Lawyers Association
- Community Health Accreditation Program (CHAP)